Friday, May 9, 2025
23.4
C
Bengaluru
My account
Get into your account.
Hot topics
Medical Rep to Chairman & Managing Director – Sunil Attavar’s Success Story
Q 1. Tell us about your journey as a pharma entrepreneur and what made you venture into pharma and stay on in pharma?
My journey started with two good decisions, one- to be a Medical Representative (MR) in Mumbai, which built a strong foundation and the other, to join Helios, a new pharma company, which was like a baptism of fire. Together, they molded me well.
I was promoted as a Front Line Manager (FLM) within a year. And after spending four excellent years in Helios, I joined Group Pharma as Product Manager (PM) and ever since, it’s been an exciting learning experience.
I was exposed to Pharma very early in life as my dad was in J L Morison, as part of the promoter-team of Warren Pharma. At home, I was the designated telephone operator and order processing clerk. Those were the days of trunk-calls - calling managers and distributors to note down orders. Hence, I was exposed to the excitement of targets, achievements, deficits and campaigns very early in my life. The idea of ‘work-life balance’ was not in vogue. One would look to their parents who worked long hours with pride making it something you wanted to emulate. Things have changed a lot but I would not trade the decision I made, to get into and stay in Pharma.
Legal Scrutiny
The October 2016 Issue of MedicinMan features articles by K. Hariram, Vivek Hattangadi, Anup Soans and has a special focus on ethics and morals in the healthcare profession. Other topics covered include new product launches, the role of emotions in pharma sales and sales coaching.
Consumer Experience in Pharmaceutical Industry
A wholesome view of the brand shapes a customer’s...
Digital in Health – Making Healthcare Patient Centric
Interview with Hanno Wolfram, author of Digital in Health
Anup...
Partner Don’t Punish
Articles by Vivek Hattangadi, Genesh Kuriakose, Pankaj Mehrotra, Salil Kallianpur and Jay Mehta
Indian Pharma Market Performance – April 2025
The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
Nimesulide – Nice or Not Nise?
Nimesulide Regulatory Status Worldwide
Nimesulide is a non-steroidal anti-inflammatory drug...
How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies
April 14, 2025
India’s pharmaceutical industry, a global powerhouse, sends...
Indian Pharma Market Performance – April 2025
The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
Nimesulide – Nice or Not Nise?
Nimesulide Regulatory Status Worldwide
Nimesulide is a non-steroidal anti-inflammatory drug...
How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies
April 14, 2025
India’s pharmaceutical industry, a global powerhouse, sends...
Indian Pharma Market Performance – April 2025
The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
Nimesulide – Nice or Not Nise?
Nimesulide Regulatory Status Worldwide
Nimesulide is a non-steroidal anti-inflammatory drug...
How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies
April 14, 2025
India’s pharmaceutical industry, a global powerhouse, sends...
Indian Pharma Market Performance – April 2025
The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
Nimesulide – Nice or Not Nise?
Nimesulide Regulatory Status Worldwide
Nimesulide is a non-steroidal anti-inflammatory drug...
How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies
April 14, 2025
India’s pharmaceutical industry, a global powerhouse, sends...
Hot topics
The Pharma Professional’s Guide
Brand Building Special Issue with articles on personal branding, brand differentiation and avoiding brand arrogance
Track and Trace: Indian Pharma – Current and Future Applicability
Pharmaceutical companies must contend with challenges from supply chain lapses (theft, diversion, S.O.P. deviations, product recalls, reverse logistics etc.) counterfeiting and stringent regulations. These challenges get compounded when dealing across the states and country business operations, besides that not only impact tangible profits but also the intangible brand credibility. In this context, there is also a credible increase in public awareness about the genuineness of medicine (in particular medicine that require cold chain) and their predictability of clinical outcomes.
Providing visibility and full traceability becomes a paramount importance to both the Industry and the Govt. – A fool proof solution not only brings transparency in the system, but can also be a key differentiator, and undoubtedly can create immense opportunities for a competitive advantage.
72nd Republic Day: What’s the Road Ahead for Indian Pharma?
“We are getting too happy, for too little”: these...
Healthcare Isn’t Working As Well As It Should – A Brief Summary Of The ZS Report 2024
The ZS report discusses how people feel about healthcare...
Indian Pharma Market Performance – April 2025
The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
Nimesulide – Nice or Not Nise?
Nimesulide Regulatory Status Worldwide
Nimesulide is a non-steroidal anti-inflammatory drug...
How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies
April 14, 2025
India’s pharmaceutical industry, a global powerhouse, sends...
Indian Pharma Market Performance – April 2025
The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
Nimesulide – Nice or Not Nise?
Nimesulide Regulatory Status Worldwide
Nimesulide is a non-steroidal anti-inflammatory drug...
How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies
April 14, 2025
India’s pharmaceutical industry, a global powerhouse, sends...
Indian Pharma Market Performance – April 2025
The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
Nimesulide – Nice or Not Nise?
Nimesulide Regulatory Status Worldwide
Nimesulide is a non-steroidal anti-inflammatory drug...
How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies
April 14, 2025
India’s pharmaceutical industry, a global powerhouse, sends...
Indian Pharma Market Performance – April 2025
The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
Nimesulide – Nice or Not Nise?
Nimesulide Regulatory Status Worldwide
Nimesulide is a non-steroidal anti-inflammatory drug...
How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies
April 14, 2025
India’s pharmaceutical industry, a global powerhouse, sends...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
Indian Pharma Market Performance – April 2025
The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
Nimesulide – Nice or Not Nise?
Nimesulide Regulatory Status Worldwide
Nimesulide is a non-steroidal anti-inflammatory drug...
Newsletter
Get important news delivered directly to your inbox and stay connected!